Clovis And Clavis' Gemcitabine Derivative Partnership Goes From Regional To Worldwide
This article was originally published in The Pink Sheet Daily
Executive Summary
Clovis Oncology and Clavis Pharma extend partnering deal on a personalized medicine approach to pancreatic cancer therapy